Compare Stocks: VANI, COCH, ASMB, and SPRY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASMB Assembly Biosciences	$20.30 +3.2%	$27.36	$19.30 ▼ $39.71	$413.31M	1.15	190,958 shs	122,028 shs
COCH Envoy Medical	$6.53 +0.5%	$6.93	$3.63 ▼ $9.54	$504.21M	1.97	39,242 shs	38,942 shs
SPRY ARS Pharmaceuticals	$3.72 -5.2%	$4.77	$3.64 ▼ $13.15	$369.46M	0.85	1.70 million shs	1.34 million shs
VANI Vivani Medical	$1.15 +1.6%	$1.27	$0.92 ▼ $1.81	$103.55M	2.35	323,485 shs	186,851 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASMB Assembly Biosciences	-0.86%	-2.43%	-16.90%	-23.07%	-32.73%
COCH Envoy Medical	+9.15%	-0.61%	-9.09%	-4.26%	-23.53%
SPRY ARS Pharmaceuticals	-2.73%	-7.33%	-3.92%	-30.86%	-56.97%
VANI Vivani Medical	+1.80%	+0.89%	-8.87%	-13.74%	-30.25%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASMB Assembly Biosciences	$20.30 +3.2%	$27.36	$19.30 ▼ $39.71	$413.31M	1.15	190,958 shs	122,028 shs
COCH Envoy Medical	$6.53 +0.5%	$6.93	$3.63 ▼ $9.54	$504.21M	1.97	39,242 shs	38,942 shs
SPRY ARS Pharmaceuticals	$3.72 -5.2%	$4.77	$3.64 ▼ $13.15	$369.46M	0.85	1.70 million shs	1.34 million shs
VANI Vivani Medical	$1.15 +1.6%	$1.27	$0.92 ▼ $1.81	$103.55M	2.35	323,485 shs	186,851 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASMB Assembly Biosciences	-0.86%	-2.43%	-16.90%	-23.07%	-32.73%
COCH Envoy Medical	+9.15%	-0.61%	-9.09%	-4.26%	-23.53%
SPRY ARS Pharmaceuticals	-2.73%	-7.33%	-3.92%	-30.86%	-56.97%
VANI Vivani Medical	+1.80%	+0.89%	-8.87%	-13.74%	-30.25%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASMB Assembly Biosciences	2.83	Moderate Buy	$47.50	133.99% Upside
COCH Envoy Medical	2.25	Hold	$21.67	231.70% Upside
SPRY ARS Pharmaceuticals	2.50	Moderate Buy	$25.00	572.95% Upside
VANI Vivani Medical	2.25	Hold	$3.75	226.66% Upside

Current Analyst Ratings Breakdown

Latest VANI, COCH, ASMB, and SPRY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/27/2026	COCH Envoy Medical	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$2.50 ➝ $25.00
10/19/2026	COCH Envoy Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
10/15/2026	ASMB Assembly Biosciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/13/2026	COCH Envoy Medical	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy
10/6/2026	COCH Envoy Medical	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$25.00
10/2/2026	VANI Vivani Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/8/2026	SPRY ARS Pharmaceuticals	Leerink Partners Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$15.00
9/1/2026	ASMB Assembly Biosciences	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$53.00
9/1/2026	ASMB Assembly Biosciences	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$52.00
9/1/2026	ASMB Assembly Biosciences	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$52.00
9/1/2026	ASMB Assembly Biosciences	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Outperform	$53.00 ➝ $45.00

(Data available from 10/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASMB Assembly Biosciences	$72.30M	5.72	N/A	N/A	$13.04 per share	1.56
COCH Envoy Medical	$240K	2,100.85	N/A	N/A	($0.42) per share	-15.55
SPRY ARS Pharmaceuticals	$84.28M	4.38	N/A	N/A	$1.16 per share	3.20
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.20 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASMB Assembly Biosciences	-$6.12M	$1.02	19.90	406.00	N/A	-0.06%	-0.02%	-0.02%	11/9/2026 (Estimated)
COCH Envoy Medical	-$23.76M	-$0.76	N/A	N/A	N/A	-11,304.83%	N/A	-144.13%	11/9/2026 (Estimated)
SPRY ARS Pharmaceuticals	-$171.30M	-$2.18	N/A	N/A	N/A	-184.24%	-256.67%	-69.63%	11/9/2026 (Estimated)
VANI Vivani Medical	-$26.61M	-$0.35	N/A	N/A	N/A	N/A	-191.05%	-70.91%	11/12/2026 (Estimated)

Latest VANI, COCH, ASMB, and SPRY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	Q3 2026	VANI Vivani Medical	-$0.07	N/A	N/A	N/A	N/A	N/A
11/9/2026	Q3 2026	ASMB Assembly Biosciences	-$0.6550	N/A	N/A	N/A	$9.07 million	N/A
11/9/2026	Q3 2026	COCH Envoy Medical	-$0.07	N/A	N/A	N/A	$0.09 million	N/A
11/9/2026	Q3 2026	SPRY ARS Pharmaceuticals	-$0.34	N/A	N/A	N/A	$41.99 million	N/A
8/13/2026	Q2 2026	ASMB Assembly Biosciences	-$0.7242	-$0.20	+$0.5242	-$0.20	$8.60 million	$13.37 million
8/13/2026	Q2 2026	SPRY ARS Pharmaceuticals	-$0.4777	-$0.63	-$0.1523	-$0.63	$31.32 million	$33.66 million
8/13/2026	Q2 2026	VANI Vivani Medical	-$0.0833	-$0.07	+$0.0133	-$0.07	N/A	N/A
8/10/2026	Q2 2026	COCH Envoy Medical	-$0.80	-$0.70	+$0.10	-$0.07	$0.05 million	$0.05 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASMB Assembly Biosciences	N/A	N/A	N/A	N/A	N/A
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
SPRY ARS Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASMB Assembly Biosciences	N/A	13.99	13.99
COCH Envoy Medical	N/A	1.73	1.61
SPRY ARS Pharmaceuticals	13.72	3.48	3.28
VANI Vivani Medical	N/A	3.25	3.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASMB Assembly Biosciences	19.92%
COCH Envoy Medical	8.59%
SPRY ARS Pharmaceuticals	68.16%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
ASMB Assembly Biosciences	3.50%
COCH Envoy Medical	7.20%
SPRY ARS Pharmaceuticals	33.80%
VANI Vivani Medical	53.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASMB Assembly Biosciences	73	20.36 million	19.65 million	Optionable
COCH Envoy Medical	47	77.19 million	71.64 million	Not Optionable
SPRY ARS Pharmaceuticals	200	99.45 million	65.83 million	Optionable
VANI Vivani Medical	36	90.20 million	42.13 million	Optionable

VANI, COCH, ASMB, and SPRY Headlines

Recent News About These Companies

Vivani Medical (NASDAQ:VANI) Shares Down 6% - What's Next?

October 23, 2026 | marketbeat.com

Vivani Medical Announces Participation in Upcoming October 2026 Investor Conferences

October 12, 2026 | biospace.comB

Vivani Medical to Participate in Maxim Growth Summit and ThinkEquity Conference in New York

October 12, 2026 | quiverquant.comQ

Vivani Medical Announces Merger Deal Involving Cortigent

September 16, 2026 | tipranks.com

Vivani Medical to Participate in Upcoming Lake Street and H.C. Wainwright Investor Conferences

September 3, 2026 | quiverquant.comQ

Vivani Medical Announces Participation in Upcoming Investor Conferences

September 3, 2026 | globenewswire.com

Analysts Offer Insights on Healthcare Companies: Vivani Medical (VANI) and InspireMD (NSPR)

August 20, 2026 | theglobeandmail.com

Vivani Medical Inc U5P

August 19, 2026 | morningstar.comM

Vivani Medical Updates Investors with Regulation FD Presentation

August 17, 2026 | tipranks.com

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026 | finance.yahoo.com

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026 | globenewswire.com

Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial

August 6, 2026 | finance.yahoo.com

ClearOne (CLRO) stock soars over 98% after hours: Here's what you need to know

August 6, 2026 | msn.com

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic ...

August 6, 2026 | finance.yahoo.com

Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial

August 6, 2026 | tipranks.com

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

July 14, 2026 | globenewswire.com

Next Frontier In Weight Loss? New Implant Looks To Lock In GLP-1 Results

July 14, 2026 | msn.com

The next GLP-1 bet? Implant draws Novo interest

July 13, 2026 | beckershospitalreview.comB

Vivani Medical

July 13, 2026 | fool.com

Weight-loss implant could one day replace Ozempic injections

July 12, 2026 | msn.com

Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal

July 9, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI, COCH, ASMB, and SPRY Company Descriptions

Assembly Biosciences NASDAQ:ASMB

$20.30 +0.63 (+3.20%)

Closing price 03:59 PM Eastern

Extended Trading

$20.30 0.00 (0.00%)

As of 04:04 PM Eastern

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Envoy Medical NASDAQ:COCH

$6.53 +0.03 (+0.49%)

Closing price 03:59 PM Eastern

Extended Trading

$6.56 +0.02 (+0.35%)

As of 04:10 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

ARS Pharmaceuticals NASDAQ:SPRY

$3.72 -0.21 (-5.23%)

Closing price 03:59 PM Eastern

Extended Trading

$3.73 +0.02 (+0.40%)

As of 04:10 PM Eastern

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Vivani Medical NASDAQ:VANI

$1.15 +0.02 (+1.59%)

Closing price 03:58 PM Eastern

Extended Trading

$1.14 -0.01 (-0.70%)

As of 04:10 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VANI, COCH, ASMB, and SPRY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VANI, COCH, ASMB, and SPRY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VANI, COCH, ASMB, and SPRY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI, COCH, ASMB, and SPRY Company Descriptions

Assembly Biosciences NASDAQ:ASMB

Envoy Medical NASDAQ:COCH

ARS Pharmaceuticals NASDAQ:SPRY

Vivani Medical NASDAQ:VANI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VANI, COCH, ASMB, and SPRY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VANI, COCH, ASMB, and SPRY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VANI, COCH, ASMB, and SPRY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI, COCH, ASMB, and SPRY Company Descriptions

Assembly Biosciences NASDAQ:ASMB

Envoy Medical NASDAQ:COCH

ARS Pharmaceuticals NASDAQ:SPRY

Vivani Medical NASDAQ:VANI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools